These results further support the development of donor reimbursement programs and can be used to guide their implementation.
After case-cost calculation at hospital level, tariff calculation at national level is the second step on the way to understanding the development of G-DRG reimbursement rates and hospital management decisions.
Our study of the challenges associated with bringing cell therapies to market also offers lessons for government officials working to oversee the development of and determine reimbursement levels for novel cell therapies.
In this article, we review current approaches to episode of care development and reimbursement.
As an ever-increasing portion of gross domestic product is spent on health care, economic considerations are given increasing importance in the development of treatment guidelines and drug reimbursement decisions.
The programs focus narrowly on such areas as management of drug development, reimbursement affairs, and regulatory affairs.
This should then be followed by controlling the development of health insurance programs with higher reimbursement rates and upgrading health insurance programs with low reimbursement rates and achieve unification step by step.
Current diagnostic reimbursement policies in the US and many EU countries do not necessarily support the development of high-value molecular tests, as reimbursement of these tests has typically been based on cost, not on value (or potential) value [ 20].
Reengineering the prelicensing research and development process to align the evidence base with the needs of reimbursement authorities may be the long-term solution, but such changes will require major intellectual and organizational developments in healthcare research, regulation, and reimbursement.
It provided the Urban Employee Basic Medical Insurance UEBMII), Urban Residents Basic Medical Insurance (URBMI), and New Rural Cooperative Medical Care (NRCMC) to cover all residents in China, enhanced the three-level health security system, and prompted the development of primary health care organizations through reimbursement limitations.
